As the dawn of 2026 illuminates our development journey, we stand at a new historical starting point, looking back on JinYi Connect's solid footprint in the Asia-Pacific market, and filled with confidence and expectations for future progress. In the new year, JinYi Interconnect will always focus on its core direction of "focusing on its own development and driving industrial innovation," using technological innovation and biomedicine as its dual engines, breaking boundaries through in-depth innovation, and writing a new chapter of high-quality development through collaborative development.
Focusing on core strengths across two tracks, JinYi Connect has leveraged Hong Kong as a strategic foothold since its inception, building a dynamic and in-depth development landscape in the fields of technology innovation and biomedicine, laying a solid foundation for further development in 2026. In the biomedicine field, relying on our parent company's global resource network, we precisely address the pain points of technology transfer, not only driving key breakthroughs in our portfolio companies such as multimodal AI diagnostic systems, but also accelerating the clinical application of cutting-edge European and American oncology therapies in the region through a "global technology - local implementation" mechanism, responding to public health needs with technological innovation. In the technology innovation field, we use cutting-edge technologies such as artificial intelligence and quantum computing as anchors to promote deep integration of technology and industry. Successful practices in areas such as energy have fully validated the feasibility of our "ecosystem resonance" strategy. In 2026, we will further focus on these two core tracks, deepening our technological accumulation and industrial synergy in our advantageous areas, making focus a distinctive feature of high-quality development.
Innovation empowers the construction of a cross-regional ecosystem. In 2026, the global innovation landscape is undergoing rapid restructuring, with Asia becoming a core hub for global innovation. In the biopharmaceutical field, an aging population is generating massive incremental demand; in the field of technological innovation, the improved digital economy infrastructure provides fertile ground for technology implementation. Facing this opportunity, JinYi Connect will leverage "ecosystem synergy" to continuously advance its three-dimensional development path: On the technology R&D side, it will deepen cooperation with top institutions such as the Singapore Agency for Science, Technology and Research (A*STAR) and RIKEN in Japan, focusing on building joint laboratories in interdisciplinary fields such as AI healthcare and quantum sensing to accelerate the commercialization of cutting-edge technologies; on the localization empowerment side, it will introduce mature incubation models and customize growth plans based on the characteristics of the Asian market, providing precise support for the industrial characteristics of different regions; on the resource integration side, it will further improve its "capital-technology-market" shared platform, promoting resource integration between Hong Kong and Southeast Asia, Japan, and South Korea, building a cross-regional innovation ecosystem, and allowing innovation vitality to be fully released through collaboration.
Global Vision, Fulfilling the Mission of Deep Local Cultivation. As an important bridge connecting global capital and Asian innovation, JinYi Connect consistently adheres to the development model of "global vision + deep local cultivation." In 2026, building upon our deepened presence in the Hong Kong market, we will fully leverage the strategic hub role of our Singapore fund company to strengthen the synergy between these two core financial centers, enabling full-cycle, full-chain empowerment of innovative projects across Asia. We will continue to focus on cutting-edge areas such as AI+biomedicine and cell and gene therapy, precisely identifying innovative companies with core technological barriers. Through diverse means including capital injection, resource integration, and commercialization empowerment, we will cultivate benchmark forces leading regional industrial development. Simultaneously, we will actively respond to regional development needs, deeply integrating advanced global technologies and concepts with local innovation demands to achieve a "two-way empowerment" development loop, continuously enhancing corporate value while driving industrial upgrading.
A new starting point carries new missions, and a new journey calls for new achievements. In 2026, JinYi Connect will dedicate itself to the innovation and biopharmaceutical industry with greater focus, a more open attitude, and more pragmatic actions, continuously progressing through innovative breakthroughs and empowering regional development through ecosystem building. We firmly believe that only by upholding a spirit of continuous improvement can we achieve steady and long-term progress; only by adhering to the path of innovation can we forge a bright future. JinYi Connect will join hands with industry partners to write a more brilliant chapter of development in the tide of the times, contributing to the improvement and full realization of the Asian innovation ecosystem.
